HomeARQT • NASDAQ
Follow
Arcutis Biotherapeutics Inc
Previous close
$9.59
Day range
$9.61 - $10.02
Year range
$1.76 - $15.40
Market cap
1.14B USD
Avg Volume
4.92M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 13.53M | 356.81% |
Operating expense | 72.45M | 2.18% |
Net income | -66.28M | 7.96% |
Net profit margin | -490.05 | 79.85% |
Earnings per share | -0.72 | 38.98% |
EBITDA | -60.78M | 10.71% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 271.86M | -33.63% |
Total assets | 341.36M | -24.02% |
Total liabilities | 252.70M | 5.43% |
Total equity | 88.67M | — |
Shares outstanding | 96.81M | — |
Price to book | 10.42 | — |
Return on assets | -48.22% | — |
Return on capital | -55.98% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -66.28M | 7.96% |
Cash from operations | -56.24M | 20.86% |
Cash from investing | -62.19M | -247.36% |
Cash from financing | 99.29M | 10,221.10% |
Net change in cash | -19.07M | 31.64% |
Free cash flow | -33.32M | 25.91% |
About
Founded
2016
Headquarters
Website
Employees
296